Maternal stress and fetoplacental cortisol regulation in small-for-gestational-age newborns


Por: Miranda, J, Benitez, L, Macías-Redondo, S, Paules, C, Gomez-Gomez, A, Basso, A, Crovetto, F, Youssef, L, Pozo, OJ, Schoorlemmer, J, Crispi, F and Gratacós, E

Publicada: 1 jun 2025 Ahead of Print: 1 may 2025
Resumen:
Objective Previous research has identified an association between maternal stress, fetal growth and the expression of glucocorticoid-related genes in the placenta, particularly 11-beta hydroxysteroid dehydrogenase-2 (HSD11 beta 2). However, to date, no studies have simultaneously explored the relationships between maternal stress, placental expression and methylation of HSD11 beta 2, and fetal cortisol metabolites according to fetal growth. The aim of the present study was to evaluate the association between perceived antenatal maternal stress, the expression and methylation of the placental HSD11 beta 2 gene, fetal cortisol metabolites in amniotic fluid and birth weight. Methods This nested case-control study, which was part of a large prospective cohort study, was conducted at two maternofetal medicine units in Barcelona, Spain (BCNatal: Hospitals Clinic and Sant Joan de D & eacute;u). We enrolled singleton pregnancies and classified neonates as small-for-gestational-age (SGA) if their birth weight was below the 10th percentile (n = 343) or as appropriate-for-gestational-age (AGA) controls (n = 399). The Perceived Stress Scale (PSS) and the State-Trait Anxiety Inventory (STAI) scores were obtained to assess maternal stress and anxiety levels. We analyzed placental HSD11 beta 2 RNA expression (n = 44 SGA and 28 AGA) and DNA methylation levels (n = 89 SGA and 34 AGA), and fetal cortisol metabolites and the activity of metabolizing enzymes in amniotic fluid (n = 135 SGA and 78 AGA) using liquid chromatography-tandem mass spectrometry. Results Median maternal perceived stress (PSS, 23 (interquartile range (IQR), 17-28) vs 20 (IQR, 15-26); P < 0.001) and median anxiety state (STAI-state, 19.0 (IQR, 14.0-29.0) vs 16.0 (IQR, 11.0-24.0); P < 0.001) scores were significantly higher in the SGA group compared with the control group. SGA cases showed lower median placental HSD11 beta 2 RNA expression (Delta Ct, 50.5 (IQR, 21.6-106.0) vs 92.7 (IQR, 62.3-118.0); P = 0.013) with similar DNA methylation levels (mean +/- SD, 10.7 +/- 3.0% vs 11.0 +/- 2.8%; P = 0.648) compared with AGA controls. Analysis of amniotic fluid revealed altered cortisol metabolism in SGA fetuses, with increased median 5 alpha-tetrahydrocortisol concentration (SGA, 0.09% (IQR, 0.06-0.15%) vs controls, 0.07% (IQR, 0.05-0.11%); P = 0.020) and activity of its related enzyme (5 alpha-reductase activity in SGA, 0.19% (IQR, 0.14-0.31%) vs controls, 0.17% (IQR, 0.12-0.22%); P = 0.007), together with a decrease in median 6-hydroxycortisol concentration (SGA, 0.09% (IQR, 0.06-0.11%) vs controls, 0.11% (IQR, 0.08-0.12%); P < 0.001) and activity of its related enzyme (CYP3A7 activity in SGA, 0.19% (IQR, 0.11-0.25%) vs controls, 0.24% (IQR, 0.17-0.33%); P < 0.001). Conclusions SGA pregnancy is associated with high perceived maternal stress and dysregulated fetoplacental cortisol metabolism. These results deepen our understanding of the pathophysiology of SGA and highlight the potential benefit of intervention to mitigate maternal stress. (c) 2025 International Society of Ultrasound in Obstetrics and Gynecology.

Filiaciones:
Miranda, J:
 Univ Barcelona, Hosp Sant Joan Deu, BCNatal Barcelona Ctr Maternal Fetal & Neonatal Me, Barcelona, Spain

 Univ Barcelona, Hosp Sant Joan Deu, Barcelona, Spain

 Univ Cartagena, Fac Med, Dept Obstet & Gynecol, Cartagena, Colombia

 Ctr Hosp Serena Mar, Dept Obstet & Gynecol, Cartagena, Colombia

 Fdn Santa Fe Bogota, Bogota, Colombia

Benitez, L:
 Univ Barcelona, Hosp Sant Joan Deu, BCNatal Barcelona Ctr Maternal Fetal & Neonatal Me, Barcelona, Spain

 Univ Barcelona, Hosp Sant Joan Deu, Barcelona, Spain

 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

Macías-Redondo, S:
 Inst Aragones Ciencias Salud IACS, Zaragoza, Spain

 Placental Pathophysiol & Fetal Programming Res Grp, Zaragoza, Spain

Paules, C:
 Univ Barcelona, Hosp Sant Joan Deu, BCNatal Barcelona Ctr Maternal Fetal & Neonatal Me, Barcelona, Spain

 Univ Barcelona, Hosp Sant Joan Deu, Barcelona, Spain

 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Inst Aragones Ciencias Salud IACS, Zaragoza, Spain

 Placental Pathophysiol & Fetal Programming Res Grp, Zaragoza, Spain

Gomez-Gomez, A:
 Hosp Mar Med Res Inst IMIM, Appl Metabol Res Grp, Barcelona, Spain

Basso, A:
 Univ Barcelona, Hosp Sant Joan Deu, BCNatal Barcelona Ctr Maternal Fetal & Neonatal Me, Barcelona, Spain

 Univ Barcelona, Hosp Sant Joan Deu, Barcelona, Spain

 A Manzoni Hosp, Dept Obstet & Gynecol, ASST Lecco, Lecce, Italy

Crovetto, F:
 Univ Barcelona, Hosp Sant Joan Deu, BCNatal Barcelona Ctr Maternal Fetal & Neonatal Me, Barcelona, Spain

 Univ Barcelona, Hosp Sant Joan Deu, Barcelona, Spain

 Inst Recerca Sant Joan Deu, Esplugues De Llobregatsp, Spain

 Inst Salud Carlos III, Primary Care Intervent Prevent Maternal & Child Ch, Barcelona, Spain

:
 Univ Barcelona, Hosp Sant Joan Deu, BCNatal Barcelona Ctr Maternal Fetal & Neonatal Me, Barcelona, Spain

 Univ Barcelona, Hosp Sant Joan Deu, Barcelona, Spain

 Hosp Clin Barcelona, Josep Carreras Leukaemia Res Inst, Univ Barcelona Campus, Barcelona, Spain

Pozo, OJ:
 Hosp Mar Med Res Inst IMIM, Appl Metabol Res Grp, Barcelona, Spain

Schoorlemmer, J:
 Inst Aragones Ciencias Salud IACS, Zaragoza, Spain

 Placental Pathophysiol & Fetal Programming Res Grp, Zaragoza, Spain

 ARAID Fdn, Zaragoza, Spain

Crispi, F:
 Univ Barcelona, Hosp Sant Joan Deu, BCNatal Barcelona Ctr Maternal Fetal & Neonatal Me, Barcelona, Spain

 Univ Barcelona, Hosp Sant Joan Deu, Barcelona, Spain

 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Ctr Biomed Res Rare Dis CIBER ER, Barcelona, Spain

Gratacós, E:
 Univ Barcelona, Hosp Sant Joan Deu, BCNatal Barcelona Ctr Maternal Fetal & Neonatal Me, Barcelona, Spain

 Univ Barcelona, Hosp Sant Joan Deu, Barcelona, Spain

 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Inst Recerca Sant Joan Deu, Esplugues De Llobregatsp, Spain

 Ctr Biomed Res Rare Dis CIBER ER, Barcelona, Spain
ISSN: 14690705





ULTRASOUND IN OBSTETRICS & GYNECOLOGY
Editorial
John Wiley & Sons Inc., 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Estados Unidos America
Tipo de documento: Article
Volumen: 65 Número: 6
Páginas: 738-748
WOS Id: 001484210000001
ID de PubMed: 40344310
imagen Green Submitted, hybrid

MÉTRICAS